Clinical Trial Update: A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

This Phase 2 trial update assesses the safety and efficacy of PRL3-Zumab in patients with solid tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PRL3-ZUMAB

Snippet

Sponsor: Intra-IMMUSG Pte Ltd | Conditions: Solid Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING